Evidence map›Paper›PMID 31344926›Full record

ReviewJournal of clinical medicine2019

Markers of Cancer Cell Invasion: Are They Good Enough?

Tatiana S Gerashchenko, Nikita M Novikov, Nadezhda V Krakhmal, Sofia Y Zolotaryova, Marina V Zavyalova, Nadezhda V Cherdyntseva, Evgeny V Denisov, Vladimir M Perelmuter

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Vitamin E in the management of pancreatic cancer: A scoping review.World journal of gastrointestinal oncology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tatiana S GerashchenkoLaboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia. t_gerashchenko@oncology.tomsk.ru.ORCID 0000-0002-7283-0092
Nikita M NovikovLaboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia.
Nadezhda V KrakhmalDepartment of Pathological Anatomy, Siberian State Medical University, 634050 Tomsk, Russia.
Sofia Y ZolotaryovaDepartment of Cytology and Genetics, Tomsk State University, 634050 Tomsk, Russia.
Marina V ZavyalovaDepartment of Pathological Anatomy, Siberian State Medical University, 634050 Tomsk, Russia.
Nadezhda V CherdyntsevaLaboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia.
Evgeny V DenisovLaboratory of Molecular Oncology and Immunology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia.ORCID 0000-0003-2923-9755
Vladimir M PerelmuterDepartment of General and Molecular Pathology, Cancer Research Institute, Tomsk National Research Medical Center, 634009 Tomsk, Russia.

Funding

Russian Science Foundation 19-75-30016
6 · The paper itself

Abstract

Invasion, or directed migration of tumor cells into adjacent tissues, is one of the hallmarks of cancer and the first step towards metastasis. Penetrating to adjacent tissues, tumor cells form the so-called invasive front/edge. The cellular plasticity afforded by different kinds of phenotypic transitions (epithelial-mesenchymal, collective-amoeboid, mesenchymal-amoeboid, and

Indexed as

cancerepithelial–mesenchymal transitionheterogeneityinvasioninvasive front

Identifiers

PMID31344926
PMCPMC6723901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.